HR 10150 · 119th Congress
To amend the Federal Food, Drug, and Cosmetic Act to provide a period of market exclusivity for botanical drugs, and for other purposes.
Latest action
Referred to the House Committee on Energy and Commerce.
Sponsor
Lauren BoebertRepublican · CO-4Profile →Cosponsors (1)
1 R